EP Patent

EP3373972A1 — Compositions for treating spinal muscular atrophy

Assigned to F Hoffmann La Roche AG · Expires 2018-09-19 · 8y expired

What this patent protects

The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R 1 , R 2 and R 3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pha…

USPTO Abstract

The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R 1 , R 2 and R 3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.

Drugs covered by this patent

Patent Metadata

Patent number
EP3373972A1
Jurisdiction
EP
Classification
—
Expires
2018-09-19
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.